Pliant Partners with Cleveland Clinic to Find New Disease Targets for Gut Fibrosis

Pliant Partners with Cleveland Clinic to Find New Disease Targets for Gut Fibrosis
Pliant Therapeutics is starting a multi-year research collaboration with Cleveland Clinic to speed the discovery of new druggable targets for gastrointestinal fibrosis, a common gut complication in patients with inflammatory bowel disease (IBD). Fibrotic strictures in the bowel, a narrowing in the intestine which can make it difficult for food material to pass through, are

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *